Zhipu (02513) responded that its cooperation with the travel platform does not involve insider information and that the business progress falls within the scope of daily operations; Hongxing Cold Chain (01641): The Hong Kong public offering was subscribed 2,309.25 times, with a per-share issue price of HKD 12.26.
Material Events:
Red Star Cold Chain (01641): Hong Kong public offering received 2,309.25 times subscription, with an issue price of HKD 12.26 per share.
BBSB INTL(08610): Public offering received 10,745.13 times subscription, with an issue price of HKD 0.6 per share.
GigaDevice (03986) Hong Kong public offering was subscribed 542.22 times, raising approximately HKD 4.611 billion net proceeds from the global offering.
Hengrui Pharma (01276): Injectable SHR-1826 has been included in the Center for Drug Evaluation’s Breakthrough Therapy Designation list.
Biocytogen-B (02315) further collaborates with Yushibo under the Option-based Evaluation Framework to advance the world's first bispecific antibody dual-drug conjugate project.
Cambridge Technology (06166)’s controlling subsidiary has been certified as a high-tech enterprise.
Zhipu (02513) responded that its cooperation with the travel platform does not involve insider information and that the business progress falls within the scope of daily operations.
ChinaSoft International (00354) invested company MiniMax (00100) listed on the Hong Kong Stock Exchange, marking a new milestone in its full-stack AI strategy.
Dali Group Holdings (01921) plans to sell a 40% stake in Dali International for 3 million Saudi Riyals, introducing a Saudi strategic investor to advance projects in the Middle East. Trading will resume on January 13.
Xixiangfeng Group (02473) plans to acquire 51% equity in Kuangshi Technology through equity acquisition or capital increase.
Jihong Co., Ltd. (02603) plans to establish a Shenzhen subsidiary to further enhance its packaging business layout.
Operating performance:
Wuxi Apptec (02359) issued a positive earnings forecast, estimating approximately CNY 19.151 billion in net profit attributable to shareholders for 2025, representing a year-on-year increase of about 102.65%.
China Resources Land (01109) reported cumulative contract sales of approximately 233.6 billion yuan in 2025, representing a year-on-year decrease of 10.5%.
Dongfeng Motor Group (00489) reported cumulative automobile sales of 1.8962 million units in 2025, reflecting a year-on-year growth of approximately 0.01%.
BOC Aviation (02588) maintains a 100% utilization rate for its owned aircraft throughout the 2025 fiscal year.
Longfor Group (00960) achieved a total contracted sales amount of 63.16 billion yuan cumulatively for the 2025 fiscal year.
361 Degrees (01361): Retail sales of the main brand products in the fourth quarter achieved approximately 10% positive year-on-year growth.
Yue Yuen Industrial (Holdings) Limited (00551) reported a consolidated cumulative net operating revenue of 8.031 billion USD for the fiscal year 2025, representing a year-on-year decrease of 1.85%.
Q Tech (01478) reported December sales of 43.08 million units of mobile camera modules, marking a 13.2% increase month-on-month and a 40.8% increase year-on-year.
Blue Moon Group (06993) anticipates a significant improvement in its financial performance for the fiscal year 2025.
Asia Pacific Resources International Holdings Limited (01104) announced a positive profit alert, expecting shareholder attributable profit for the first half of the 2025/26 fiscal year to range between approximately 1.4 billion and 1.9 billion HKD, reversing from a loss in the previous year.
China Lilanz (01234): The retail sales value of 'LILANZ' products in the fourth quarter achieved a high single-digit year-on-year growth.
